Le Lézard10 小时
Sanochemia/SPL: Investigational Iron-Based MRI Contrast Agent Meets Primary Endpoints in ...
Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen, The ...